Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on (3R) 3 tertbutyldimethylsiloxy 6 dialkoxyphosphono 5 oxo tertbutyl hexanate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102212081B details a novel asymmetric synthesis for statin side chains, offering high purity and eliminating resolution steps for cost-effective manufacturing.
Novel asymmetric synthesis of (3R)-3-tertbutyldimethylsiloxy-6-dialkoxyphosphono-5-oxo-tertbutyl hexanate via chiral resolution-free route for high-purity statin production.